In a study of patients with type 2 diabetes and chronic kidney disease, canagliflozin, an SGLT2 inhibitor, decreased the risk of end-stage renal disease by 32% compared with placebo.
In a phase 3 trial, tenapanor, which reduces paracellular phosphate transport in the intestine, lowered elevated serum phosphorus in patients on hemodialysis.
Patients treated with the mineralocorticoid receptor antagonist had a higher frequency of moderate hyperkalemia compared with placebo recipients.
In a small study of hemodialysis patients with secondary hyperparathyroidism, microwave ablation achieved higher rates of the recommended target levels of intact parathyroid hormone.
Sertraline is modestly more effective than cognitive behavioral therapy (CBT) in treating depressive symptoms in patients on maintenance hemodialysis (HD), new study findings suggest. The study, led by Rajnish Mehrotra, MD, MS, of the Kidney Research Institute at the University of Washington in Seattle, also found that engagement interviews had no effect on patient acceptance…
Dialysis patients were more likely to die from pre-existing cancers and transplant recipients from de novo cancers.
Higher consumption of fruit and vegetables linked to lower risk for all-cause, non-CVD mortality
Many are calling for standard dialysis coverage for undocumented immigrants with end-stage renal disease.
Patients who remain on loop diuretics after starting hemodialysis (HD) experience lower rates of hospitalization and intradialytic hypotension during the first year on HD, a study found.
Patients with Medicare, Medicaid more likely to use arteriovenous fistula, graft by fourth dialysis month.